Perimeter Medical Imaging Appoints Dr. Franklyn Prendergast to Board of Directors

Toronto, Canada, November 16, 2017 --(PR.com)-- Perimeter Medical Imaging Inc., a developer of real time imaging systems for in-surgery tissue assessment, is pleased to announce that Dr. Franklyn Prendergast, will be joining Perimeter’s Board of Directors. Dr. Prendergast spent his entire professional career at Mayo Clinic in Rochester, MN. He retired from Mayo in December of 2014.

At Mayo Dr. Prendergast held sundry scientific and administrative positions. He is the emeritus Director of the Mayo Clinic Comprehensive Cancer Center and of the Mayo Clinic Center for Individualized Medicine; Emeritus Chair of the Department of Biochemistry and Molecular Biology, Emeritus member of the Mayo Clinic Board of Governors and Board of Trustees and also was a member of the Mayo Foundation Executive Committee. His last academic appointment was as the Edmond and Marion Guggenheim Professor of Biochemistry and Molecular Biology and Professor of Molecular Pharmacology and Experimental Therapeutics.
Currently Dr. Prendergast serves on the Board of Directors for the Infectious Disease Research Institute, Cancer Genetics Inc., Medibio, Cyclica and is a member of the Advisory Committee for the Biden Cancer Initiative.

Dr. Prendergast recently retired after 22 years as a member of the Board of Directors of Eli Lilly and Co. He has also worked extensively with the National Institutes of Health in a variety of capacities including Board of Advisors for the Division of Research Grants, Scientific Advisory Board of the National Cancer Institute, the National Cancer Advisory Board and National Advisory General Medical Sciences Council. His roles at the National Institutes of Health have been advisory and extensively as a reviewer on enumerable number of grant review committees.

Dr. Prendergast will be actively involved as a member of Perimeter’s Board of Directors and Clinical Board of Advisors, acting as a conduit between these boards. The combination of his extensive medical and business background and relationships will be invaluable to Perimeter. He will support Perimeter’s ongoing clinical engagement, validation of market entry strategy and fundraising efforts.

Dr. Prendergast will be joining Perimeter’s advisors, Dr. Ted James, Chief of Breast Surgery at Beth Israel, Harvard Medical School, and Brian Wilson, PhD, Senior Scientist, Princess Margaret Cancer Centre, Head of Medical Imaging and Biophysics – OCI, and Core Lead, Techna Institute for the Advancement of Technology for Health (Techna) at UHN, who is a world renown expert in optical imaging in oncology. In addition, Perimeter is actively engaged with MD Anderson, Memorial Sloan Kettering and now Mayo Clinic for early clinical assessment.

Paul Weber, CEO at Perimeter notes that “this appointment is incredible validation of Perimeter’s approach to solving the unmet need for in-surgery tissue visualization. We could not be happier with the engagement from world renowned experts like Dr. Prendergast, and Key Opinion Leaders (KOLs) across North American and Europe.”

About Perimeter Medical Imaging Inc.

Perimeter Medical Imaging develops, patents and commercializes advanced surgical imaging tools that allow surgeons, radiologists and pathologists to better assess microscopic tissue structures during the surgical procedure. Perimeter’s OTIS™ is the only solution that provides rapid, automated, micron resolution visualization of the entire surface of the excised specimen, while reliably representing orientation for improved in-surgery decisions. Perimeter is a privately owned Canadian company.

For more information, visit www.perimetermed.com.

For more information visit us on the web at www.perimetermed.com or email us at pweber@perimetermed.com